Pacira BioSciences, Inc. (PCRX)

Fixed asset turnover

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	US$ in thousands	700,966	674,978	666,823	541,533	420,830
Property, plant and equipment	US$ in thousands	—	—	254,389	264,811	136,688
Fixed asset turnover		—	—	2.62	2.04	3.08

December 31, 2024 calculation

Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $700,966K ÷ $—K
= —

The fixed asset turnover ratio for Pacira BioSciences, Inc. has shown some fluctuation over the years based on the provided data.

In December 31, 2020, the fixed asset turnover was 3.08, indicating that the company generated $3.08 in revenue for every dollar invested in fixed assets. This was a strong performance, suggesting efficient utilization of fixed assets to generate sales.

However, by December 31, 2021, the fixed asset turnover decreased to 2.04, which may indicate a decline in efficiency in generating revenue from fixed assets. This could be due to factors such as changes in sales volume or inefficient utilization of fixed assets.

The ratio improved in December 31, 2022, to 2.62, signaling a better utilization of fixed assets to generate revenue compared to the previous year, but it still remains below the level achieved in 2020.

Unfortunately, the data for December 31, 2023, and December 31, 2024, are not available (indicated by "—"), which limits a more current analysis.

Overall, the fluctuation in the fixed asset turnover ratio indicates varying efficiency levels in utilizing fixed assets to generate sales over the years, emphasizing the importance of closely monitoring and managing asset utilization in the company's operations.